Re: Randomized Double-Blind Factorial Trial of Three Treatments to Reduce the Prevalence of Precancerous Gastric Lesions
Open Access
- 4 October 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 98 (19), 1426
- https://doi.org/10.1093/jnci/djj388
Abstract
We congratulate You et al. ( 1 ) for the successful completion of their chemoprevention trial. Their results have clear implications for gastric cancer prevention. As emphasized by the authors, all available reports conclude that curing Helicobacter pylori infection is a promising strategy to control gastric cancer. Previously, we supplied the authors with raw data from our Colombian chemoprevention trial at 6 years of follow-up ( 2 , 3 ) . Because our published conclusions, based on the same data, differed considerably from theirs ( 1 ) , we would like to comment on the discrepant interpretations of our results.Keywords
This publication has 5 references indexed in Scilit:
- Randomized Double-Blind Factorial Trial of Three Treatments To Reduce the Prevalence of Precancerous Gastric LesionsJNCI Journal of the National Cancer Institute, 2006
- Long term follow up of patients treated for Helicobacter pylori infectionGut, 2005
- RESPONSE: Re: Chemoprevention of Gastric Dysplasia: Randomized Trial of Antioxidant Supplements and Anti-Helicobacter pylori TherapyJNCI Journal of the National Cancer Institute, 2001
- Chemoprevention of Gastric Dysplasia: Randomized Trial of Antioxidant Supplements and Anti-Helicobacter pylori TherapyJNCI Journal of the National Cancer Institute, 2000
- Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers.Journal of Epidemiology and Community Health, 1978